Treatment of artificial esophageal ulcerations after EMR by endoscopic transplantation of autologous oral mucosal epithelial cell sheets

Treatment of artificial esophageal ulcerations after EMR by endoscopic transplantation of autologous oral mucosal epithelial cell sheets - Treatment of artificial esophageal ulcerations after EMR by endoscopic transplantation of autologous oral mucosal epithelial cell sheets

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000473

Enrollment

Registered

2006-08-15

Start date

2006-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial esophageal ulcerations after EMR

Interventions

(1) The oral mucosal tissue is taken from the patient. (2) The cultured autologous oral mucosal epithelial cell sheets are transplanted onto the artificial esophageal ulcerations after EMR.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will receive esophageal EMR

Exclusion criteria

Exclusion criteria: Oral cancers Diabetes Mellitus Steroid-administrated Chemotherapy Radiotherapy Double cancers

Design outcomes

Secondary

Measure	Time frame
Presence of pain Period until beginning to eat	—

Primary

Measure	Time frame
Sakita-Miwa classification The size of ulceration	—

Countries

Japan

Contacts

Public ContactTakeshi Ohki

Tokyo Women's Medical University Department of Surgery, Institute of Gastroenterology

ohki@ige.twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026